Company / Cash & Equivalents
AGENUS INC Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$3.0M
FY2025
5-year range
$3.0M / $291.9M
FY2021-FY2025
Trend
-92.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents has declined for 3 consecutive years, from $292M in FY2022 to $3M in FY2025.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of -45.4%.
Declined from $179M to $3M over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -78.3%
- 5-Year CAGR
- -45.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- AGENUS INC's cash & equivalents has declined for 3 consecutive years.
- 5-year CAGR of -45.4%, indicating a declining trend.
- In FY2025, cash & equivalents decreased 92.6% year-over-year.
- Peak cash & equivalents was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -8.76 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.0M | -92.6% |
| FY2024 | $40.4M | -77.4% |
| FY2023 | $178.7M | -38.8% |
| FY2022 | $291.9M | +0.0% |
| FY2021 | $291.9M | +372.3% |
| FY2020 | $61.8M | +16.5% |
| FY2019 | $53.1M | +0.0% |
| FY2018 | $53.1M | -11.9% |
| FY2017 | $60.2M | -15.8% |
| FY2016 | $71.4M | -47.7% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026